US 7115262
Chimeric protein for prevention and treatment of HIV infection
granted A61KA61K39/395
Quick answer
US patent 7115262 (Chimeric protein for prevention and treatment of HIV infection) held by The United States of America, as represented by the Department of Health and Human Services expires Mon Sep 28 2026 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Department of Health and Human Services
- Grant date
- Tue Oct 03 2006 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 28 2026 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 31
- CPC classes
- A61K, A61K39/395